Shandong Weigao Sets Comprehensive Workforce Diversity and Inclusion Policy

Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) has provided an update.

Shandong Weigao Group Medical Polymer Company Limited has adopted a formal workforce diversity policy that emphasizes building a diverse and inclusive senior management and wider workforce to support sustainable operations and enhance shareholder value. The company defines diversity broadly, covering gender, age, ethnicity, education, professional experience and other factors, and commits to merit-based appointments, equal opportunity in all employment decisions and non-discriminatory practices.

The policy mandates a safe, respectful workplace with zero tolerance for discrimination, harassment or victimization, and applies across recruitment, training, compensation, evaluation, promotion and dismissal. Weigao may set measurable diversity objectives, including gender and other targets, to be disclosed in its corporate governance report, and will use regular training to raise employees’ awareness of diversity and inclusion and foster a more open, innovative organizational culture.

The most recent analyst rating on (HK:1066) stock is a Hold with a HK$5.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.

More about Shandong Weigao Group Medical Polymer Co

Shandong Weigao Group Medical Polymer Company Limited is a medical device manufacturer based in China, focusing on high polymer medical products and related supplies for healthcare institutions. The group operates across various medical segments, emphasizing sustainable business performance and long-term value creation for shareholders within the healthcare sector.

Average Trading Volume: 15,774,087

Technical Sentiment Signal: Sell

Current Market Cap: HK$20.08B

Learn more about 1066 stock on TipRanks’ Stock Analysis page.